Loading...
XNSE
TAKE
Market cap42mUSD
Nov 12, Last price  
26.16INR
Name

Take Solutions Ltd

Chart & Performance

D1W1MN
XNSE:TAKE chart
P/E
10.21
P/S
EPS
2.56
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-49.71%
Revenues
0k
-100.00%
1,821,621,0002,939,071,0003,354,347,0003,517,730,0005,002,998,0007,036,600,0008,319,720,0008,155,400,0007,304,270,00010,301,310,00013,445,560,00015,872,430,00020,389,990,00022,128,990,0007,740,150,0006,551,930,0001,890,702,000656,080,0000
Net income
375m
P
330,418,000539,358,000539,986,000362,864,000735,516,000941,590,000794,700,000580,000,000698,830,0001,196,540,0001,307,220,0001,604,560,0001,772,960,000-123,600,000-4,520,240,000-7,822,530,000-1,002,644,000-1,196,200,000374,670,000
CFO
-162m
L
120,021,000506,134,000666,616,000182,633,000589,848,0001,154,660,0001,166,260,000998,250,000787,300,0001,481,250,000475,500,0001,039,750,0001,035,740,0002,111,440,0001,352,390,000296,170,000200,156,00093,160,000-161,800,000
Dividend
Aug 01, 20190.4 INR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
IPO date
Aug 27, 2007
Employees
Domiciled in
IN
Incorporated in
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT